Similar articles

• New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways.

  Burris H 3rd, Rocha-Lima C. Burris H 3rd, et al. Oncologist. 2008 Mar;13(3):289-98. doi: 10.1634/theoncologist.2007-0134. Oncologist. 2008. PMID: 18378539 Review.
• Improving treatment of pancreatic cancer.

  Philip PA. Philip PA. Lancet Oncol. 2008 Jan;9(1):7-8. doi: 10.1016/S1470-2045(07)70391-1. Lancet Oncol. 2008. PMID: 18177814 Clinical Trial. No abstract available.
• [Salvage chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer: survival benefit in selected patients].

  Lee JL, Kim YT. Lee JL, et al. Korean J Gastroenterol. 2008 Jul;52(1):59-63. Korean J Gastroenterol. 2008. PMID: 19077495 Korean. No abstract available.
• Palliative chemotherapy for pancreatic malignancies.

  Mehta SP. Mehta SP. Surg Clin North Am. 2010 Apr;90(2):365-75. doi: 10.1016/j.suc.2009.12.005. Surg Clin North Am. 2010. PMID: 20362792 Review.
• Recent updates on the role of chemotherapy in pancreatic cancer.

  Burris HA 3rd. Burris HA 3rd. Semin Oncol. 2005 Aug;32(4 Suppl 6):S1-3. doi: 10.1053/j.seminoncol.2005.06.022. Semin Oncol. 2005. PMID: 16143160 Review.